HELL YES—Eli Lilly CEO now admit the #insulin tweet flap “probably” signals they need to bring down cost. Twitter trolling is working. As I reported—@LillyPad execs went into full raging panic when the “free insulin” fake tweet went out. Keep pressure on!
arstechnica.com/science/2022…
Nov 21, 2022 · 8:29 PM UTC
If only to keep pushing for lower insulin prices… it’s worth staying on Twitter. Cuz we need to hit @LillyPad at every turn, as well as pressure @sanofi @Diabetes_Sanofi and @novonordisk to stop price gouging insulin.
UPDATE—Just learned that Eli Lilly executives are raging and furious at losing $20 billion in market cap from this stunt with @TwitterBlue. It’s too bad they don’t see their own damn insulin price gouging as the actual problem. Karma @LillyPad, karma.
Also let’s not forget all those in congress who voted against insulin price caps.
There are barbaric crimes against humanity committed by big insulin makers every day. Parents are literally choosing between food on the table vs insulin for their children. This cannot go on… especially when it’s such a readily available drug that’s cheap to make.
Eli Lilly = Martin Shkreli. Prove me wrong @LillyPad.
























